Polpharma SA

With multiple biosimilars already on the market and more in the pipeline, Polpharma Biologics has penned a strategic cooperation agreement with China-based CDMO Chime Biologics designed to advance the

Polpharma has announced a collaboration with Indian player MSN Laboratories that will see the Polish firm distribute MSN’s hospital portfolio in its home market. Billing itself as “the leader of th

Poland’s biopharma sector is best known for its strengths in generics and biosimilars, with companies like Polpharma SA providing central Europe and beyond with a reliable flow of affordable off-pat

Medicines for Europe’s 30th annual conference in Dublin earlier this month saw a packed house for its concluding panel, which brought together six leading executives from top European off-patent indus